B7-H3 promotes cell migration and invasion through the Jak2/Stat3/MMP9 signaling pathway in colorectal cancer

Molecular Medicine Reports

Volumn 12, Issue 4, 2015, Pages 5455-5460

  Liu, Fen ^a   Zhang, Ting ^a   Zou, Shitao ^a   Jiang, Bo ^a   Hua, Dong ^a  

^a JIANGNAN UNIVERSITY   (China)

Author keywords

B7 H3; Colorectal cancer; Jak2 Stat3 signaling pathway

Indexed keywords

B7 H3 PROTEIN; GELATINASE B; JANUS KINASE 2; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; STAT3 PROTEIN; TUMOR PROTEIN; UNCLASSIFIED DRUG; B7 ANTIGEN; CD276 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; ASTROCYTE; CELL INVASION; CELL MIGRATION; COLORECTAL CANCER; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR INVASION; UPREGULATION; WESTERN BLOTTING; WOUND HEALING; ZYMOGRAPHY; CELL MOTION; COLORECTAL TUMOR; GENE EXPRESSION; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

B7 ANTIGENS; CELL LINE, TUMOR; CELL MOVEMENT; COLORECTAL NEOPLASMS; GENE EXPRESSION; HUMANS; JANUS KINASE 2; MATRIX METALLOPROTEINASE 9; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; UP-REGULATION;

EID: 84940524030     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2015.4050     Document Type: Article

References (40)

1. Siegel R, Desantis C and Jemal A: Colorectal cancer statistics, 2014. CA Cancer J Clin 64: 104-117, 2014.
2. Sun M, Richards S, Prasad DV, Mai XM, Rudensky A and Dong C: Characterization of mouse and human B7-H3 genes. J Immunol 168: 6294-6297, 2002.
3. Ingebrigtsen VA, Boye K, Nesland JM, Nesbakken A, Flatmark K and Fodstad Ø: B7-H3 expression in colorectal cancer: Associations with clinicopathological parameters and patient outcome. BMC Cancer 14: 602, 2014.
4. + colorectal cancer cells is associated with cancer progression and survival in human patients. J Surg Res 188: 396-403, 2014.
5. Hu Y, Lv X, Wu Y, Xu J, Wang L, Chen W, Zhang W, Li J, Zhang S and Qiu H: Expression of costimulatory molecule B7-H3 and its prognostic implications in human acute leukemia. Hematology 20: 187-195, 2015.
6. Baral A, Ye HX, Jiang PC, Yao Y and Mao Y: B7-H3 and B7-H1 expression in cerebral spinal fuid and tumor tissue correlates with the malignancy grade of glioma patients. Oncol Lett 8: 1195-1201, 2014.
7. Wang F, Wang G, Liu T, Yu G, Zhang G and Luan X: B7-H3 was highly expressed in human primary hepatocellular carcinoma and promoted tumor progression. Cancer Invest 32: 262-271, 2014.
8. Sun J, Mao Y, Zhang YQ, Guo YD, Mu CY, Fu FQ and Zhang XG: Clinical signifcance of the induction of macrophage differentiation by the costimulatory molecule B7-H3 in human non-small cell lung cancer. Oncol Lett 6: 1253-1260, 2013.
9. Maeda N, Yoshimura K, Yamamoto S, Kuramasu A, Inoue M, Suzuki N, Watanabe Y, Maeda Y, Kamei R, Tsunedomi R, et al: Expression of B7-H3, a potential factor of tumor immune evasion in combination with the number of regulatory T cells, affects against recurrence-free survival in breast cancer patients. Ann Surg Oncol 21 (Suppl 4): S546-S554, 2014.
10. Roth TJ, Sheinin Y, Lohse CM, Kuntz SM, Frigola X, Inman BA, Krambeck AE, McKenney ME, Karnes RJ, Blute ML, et al: B7-H3 ligand expression by prostate cancer: A novel marker of prognosis and potential target for therapy. Cancer Res 67: 7893-7900, 2007.
11. Chen X, Bai Y, Cui W, Wang Z, Zhang G, Xu Y, Zhu X, Li Y and Wang JH: Effects of B7-H3 on the infammatory response and expression of MMP-9 in mice with pneumococcal meningitis. J Mol Neurosci 50: 146-153, 2013.
12. Wang J, Chong KK, Nakamura Y, Nguyen L, Huang SK, Kuo C, Zhang W, Yu H, Morton DL and Hoon DS: Hoon. B7-H3 associated with tumor progression and epigenetic regulatory activity in cutaneous melanoma. J Invest Dermatol 133: 2050-2058, 2013.
13. Zhao X, Li DC, Zhu XG, Gan WJ, Li Z, Xiong F, Zhang ZX, Zhang GB, Zhang XG and Zhao H: B7-H3 overexpression in pancreatic cancer promotes tumor progression. Int J Mol Med 31: 283-291, 2013.
14. Ingebrigtsen VA, Boye K, Tekle C, Nesland JM, Flatmark K and Fodstad O: B7-H3 expression in colorectal cancer: Nuclear localization strongly predicts poor outcome in colon cancer. Int J Cancer 131: 2528-2536, 2012.
15. Artacho-Cordón F, Ríos-Arrabal S, Lara PC, Artacho-Cordón A, Calvente I and Nnñez MI: Matrix metalloproteinases: Potential therapy to prevent the development of second malignancies after breast radiotherapy. Surg Oncol 21: e143-e151, 2012.
16. Hu S, Li L, Yeh S, Cui Y, Li X, Chang HC, Jin J and Chang C: Infltrating T cells promote prostate cancer metastasis via modulation of FGF11 miRNA-541 androgen receptor (AR) >MMP9 signaling. Mol Oncol 9: 44-57, 2015.
17. Jian H, Zhao Y, Liu B and Lu S: SEMA4b inhibits MMP9 to prevent metastasis of non-small cell lung cancer. Tumour Biol 35: 11051-11056, 2014.
18. Jang SY, Kim A, Kim JK, Kim C, Cho YH, Kim JH, Kim CH and Lee JY: Metformin inhibits tumor cell migration via down-regulation of MMP9 in tamoxifen-resistant breast cancer cells. Anticancer Res 34: 4127-4134, 2014.
19. Zhou DN, Deng YF, Li RH, Yin P and Ye CS: Concurrent alterations of RAGE, RECK and MMP9 protein expression are relevant to Epstein-Barr virus infection, metastasis and survival in nasopha-ryngeal carcinoma. Int J Clin Exp Pathol 7: 3245-3254, 2014.
20. Huang Q, Lan F, Wang X, Yu Y, Ouyang X, Zheng F, Han J, Lin Y, Xie Y, Xie F, et al: IL-1β-induced activation of p38 promotes metastasis in gastric adenocarcinoma via upregulation of AP-1/c-fos, MMP2 and MMP9. Mol Cancer 13: 18, 2014.
21. Li L, Tan J, Zhang Y, Han N, Di X, Xiao T, Cheng S, Gao Y and Liu Y: DLK1 promotes lung cancer cell invasion through upregu-lation of MMP9 expression depending on Notch signaling. PLoS One 9: e91509, 2014.
22. Han S, Han L, Yao Y, Sun H, Zan X and Liu Q: Activated hepatic stellate cells promote hepatocellular carcinoma cell migration and invasion via the activation of FAK-MMP9 signaling. Oncol Rep 31: 641-648, 2014.
23. Feng X, Miao G, Han Y and Xu Y: CARMA3 is overexpressed in human glioma and promotes cell invasion through MMP9 regulation in A172 cell line. Tumour Biol 35: 149-154, 2014.
24. Song H, Tian Z, Qin Y, Yao G, Fu S and Geng J: Astrocyte elevated gene-1 activates MMP9 to increase invasiveness of colorectal cancer. Tumour Biol 35: 6679-6685, 2014.
25. Kim HC, Kim YS, Oh HW, Kim K, Oh SS, Kim JT, Kim BY, Lee SJ, Choe YK, Kim DH, et al: Collagen triple helix repeat containing 1 (CTHRC1) acts via ERK-dependent induction of MMP9 to promote invasion of colorectal cancer cells. Oncotarget 5: 519-529, 2014.
26. Wei SC, Tsao PN, Weng MT, Cao Z and Wong JM: Flt-1 in colorectal cancer cells is required for the tumor invasive effect of placental growth factor through a p38-MMP9 pathway. J Biomed Sci 20: 39, 2013.
27. Kale S, Raja R, Thorat D, Soundararajan G, Patil TV and Kundu GC: Osteopontin signaling upregulates cyclooxy-genase-2 expression in tumor-associated macrophages leading to enhanced angiogenesis and melanoma growth via α9β1 integrin. Oncogene 33: 2295-2306, 2014.
28. Rangaswami H, Bulbule A and Kundu GC: Nuclear factor-inducing kinase plays a crucial role in osteopontin-induced MAPK/IkappaBalpha kinase-dependent nuclear factor kappaB-mediated promatrix metalloproteinase-9 activation. J Biol Chem 279: 38921-38935, 2004.
29. Du W, Hong J, Wang YC, Zhang YJ, Wang P, Su WY, Lin YW, Lu R, Zou W P, Xiong H and Fang JY: Inhibition of JAK2/STAT3 signalling induces colorectal cancer cell apoptosis via mito-chondrial pathway. J Cell Mol Med 16: 1878-1888, 2012.
30. Xiong H, Chen ZF, Liang QC, Du W, Chen HM, Su WY, Chen GQ, Han ZG and Fang JY: Inhibition of DNA methyl-transferase induces G2 cell cycle arrest and apoptosis in human colorectal cancer cells via inhibition of JAK2/STAT3/STAT5 signalling. J Cell Mol Med 13: 3668-3679, 2009.
31. Xiong H, Zhang ZG, Tian XQ, Sun DF, Liang QC, Zhang YJ, Lu R, Chen YX and Fang JY: Inhibition of JAK1, 2/STAT3 signaling induces apoptosis, cell cycle arrest and reduces tumor cell invasion in colorectal cancer cells. Neoplasia 10: 287-297, 2008.
32. Zhang T, Jiang B, Zou ST, Liu F and Hua D: Overexpression of B7-H3 augments anti-apoptosis of colorectal cancer cells by Jak2-STAT3. World J Gastroenterol 21: 1804-1813, 2015.
33. Kessenbrock K, Plaks V and Werb Z: Matrix metalloproteinases: Regulators of the tumor microenvironment. Cell 141: 52-67, 2010.
34. Curran S and Murray GI: Matrix metalloproteinases: Molecular aspects of their roles in tumour invasion and metastasis. Eur J Cancer 36: 1621-1630, 2000.
35. Egeblad M and Werb Z: New functions for the matrix metal-loproteinases in cancer progression. Nat Rev Cancer 2: 161-174, 2002.
36. Tekle C, Nygren MK, Chen YW, Dybsjord I, Nesland JM, Maelandsmo GM and Fodstad O: B7-H3 contributes to the metastatic capacity of melanoma cells by modulation of known metastasis-associated genes. Int J Cancer 130: 2282-2290, 2012.
37. Zhang X, Yin P, Di D, Luo G, Zheng L, Wei J, Zhang J, Shi Y, Zhang J and Xu N: IL-6 regulates MMP-10 expression via JAK2/STAT3 signaling pathway in a human lung adenocar-cinoma cell line. Anticancer Res 29: 4497-4501, 2009.
38. Senft C, Priester M, Polacin M, Schröder K, Seifert V, Kögel D and Weissenberger J: Inhibition of the JAK-2/STAT3 signaling pathway impedes the migratory and invasive potential of human glioblastoma cells. J Neurooncol 101: 393-403, 2011.
39. Reis ST, Pontes-Junior J, Antunes AA, Dall'Oglio M F, Dip N, Passerotti CC, Rossini GA, Morais DR, Nesrallah AJ, Piantino C, et al: miR-21 may acts as an oncomir by targeting RECK, a matrix metalloproteinase regulator, in prostate cancer. BMC Urol 12: 14, 2012.
40. Liu H, Tekle C, Chen YW, Kristian A, Zhao Y, Zhou M, Liu Z, Ding Y, Wang B, Mælandsmo GM, et al: B7-H3 silencing increases paclitaxel sensitivity by abrogating Jak2/Stat3 phos-phorylation. Mol Cancer Ther 10: 960-971, 2011.